Publicacións nas que colabora con J. García González (32)

2024

  1. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

    Frontiers in Immunology, Vol. 15

  2. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

    Molecular and Cellular Proteomics, Vol. 23, Núm. 10

2023

  1. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  2. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

  3. Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients

    Pathology

2022

  1. Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

    Translational Lung Cancer Research, Vol. 11, Núm. 10, pp. 1995-2009

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial

    Molecular Oncology, Vol. 15, Núm. 1, pp. 43-56

  3. Current status and future perspectives of liquid biopsy in small cell lung cancer

    Biomedicines, Vol. 9, Núm. 1, pp. 1-22

  4. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

  5. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

    Cancer Immunology, Immunotherapy, Vol. 70, Núm. 5, pp. 1177-1188

  6. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

2020

  1. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

  2. PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

  2. Evaluation of the lung immune prognostic index in advanced nonsmall cell lung cancer patients under nivolumab monotherapy

    Translational Lung Cancer Research, Vol. 8, Núm. 6, pp. 1078-1085

  3. Lung Cancer and Liquid Biopsy: Realities and Challenges in Routine Clinical Practice

    Archivos de Bronconeumologia

  4. Lung Cancer and Liquid Biopsy: Realities and Challenges in Routine Clinical Practice

    Archivos de Bronconeumologia, Vol. 55, Núm. 6, pp. 289-290

2018

  1. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

    Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473

  2. Impact of the 8th edition AJCC classification in early stage lung cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii483-viii484